NCT04970823

Brief Summary

Pediatric intravenous injection is one of the most painful events that children may be exposed to during hospitalization or illness, and it is also the most routinely performed invasive procedure. The purpose of this study is to examine the effectiveness of somatosensory interactive games on intravenous pain relief for preschool children, and to establish a VR (virtual reality) game environment for school-age children. Using a randomized experimental study, the data came from the pediatric ward. The results will show whether there is a statistically significant difference between the experimental group and the control group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
202

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 21, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

July 21, 2021

Status Verified

January 1, 2021

Enrollment Period

10 months

First QC Date

June 30, 2021

Last Update Submit

July 11, 2021

Conditions

Keywords

school-age childreninjectionpainSomatosensory interactive games

Outcome Measures

Primary Outcomes (4)

  • Changes in children's pain from baseline to after intravenous injection

    Using Wong-Baker Faces Pain Rating Scale to measure pain. There are 6 faces in the Wong-Baker Pain Scale. The first face represents a pain score of 0, and indicates "no hurt". The second face represents a pain score of 2, and indicates "hurts a little bit." The third face represents a pain score of 4, and indicates "hurts a little more". The fourth face represents a pain score of 6, and indicates "hurts even more". The fifth face represents a pain score of 8, and indicates "hurts a whole lot"; the sixth face represents a pain score of 10, and indicates "hurts worst." Nurses, pre-school children by the assistance of caregivers, and school-age children were asked to evaluate the pain levels experienced by the children receiving intravenous injections.

    O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)

  • Changes in children's fear from baseline to after intravenous injection

    Using Children's Fear scale to measure the fear level. Score the chosen face from 0 (the left-most face) to 4 (the last face). This face \[point to the left-most face\] shows no anxiety at all, this faces shows a little bit more \[point to second face from left\], a bit more \[sweep finger along scale\], right up to extreme anxiety \[point to the last face on the right\]. Nurses, pre-school children by the assistance of caregivers, and school-age children were asked to evaluate the fear levels experienced by the children receiving intravenous injections.

    O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)

  • Changes in children's emotion from baseline to after intravenous injection

    Using Children's Emotional Management Scales to measure the emotion level. The scale includes five observed emotional behavior categories, facial expression, vocalization, activity, interaction, and level of cooperation. Each category is scored from 1-5 points, the lowest total score is 5 points, and the highest score is 25 points. The higher the score, the more negative emotional behavior. Nurses, pre-school children by the assistance of caregivers, and school-age children were asked to evaluate the emotion levels experienced by the children receiving intravenous injections.

    O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)

  • semi-structed interviews

    After intravenous injection, a semi-structured qualitative interview was conducted with selected and their parent to understand the differences in experience before and after intervention.

    immediately after intravenous injection

Study Arms (2)

The somatosensory interactive game

EXPERIMENTAL

The somatosensory interactive game, an independent nursing intervention, promotes pain relief on the experimental group.

Device: The somatosensory interactive game for preschool children

A VR (virtual reality) game

EXPERIMENTAL

A VR (virtual reality) game promotes pain relief on the experimental group.

Device: A VR (virtual reality) game for school-age children

Interventions

The somatosensory interactive game, an independent nursing intervention, promotes pain relief for preschool children.

The somatosensory interactive game

A VR (virtual reality) game environment promotes pain relief for school-age children.

A VR (virtual reality) game

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • years old, normal consciousness, preschool children who need intravenous injection.
  • years old, normal consciousness, school-age children who need intravenous injection.
  • Parents of children need to be conscious and able to talk in Chinese.

You may not qualify if:

  • years old preschool children with developmental delay, epilepsy, heart disease, chemotherapy, visual and hearing impaired, obese, and have received more than 2 intravenous injections.
  • year-old school-age children with developmental delay, epilepsy, heart disease, chemotherapy, visual and hearing impaired, obese, and have received more than 2 intravenous injections.
  • The child's parents cannot express and communicate effectively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 640, Taiwan

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hui-Mei Chen, OTHERS

    NTUH Yunlin Branch

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2021

First Posted

July 21, 2021

Study Start

March 8, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

July 21, 2021

Record last verified: 2021-01

Locations